Related references
Note: Only part of the references are listed.Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors
Kelsey L. Watson et al.
JOURNAL OF NEUROSURGERY (2017)
Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1 Population-Based Approach
Anna R. Terry et al.
STROKE (2016)
Clinical Characteristics of Pruritus in Neurofibromatosis 1
Emilie Brenaut et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T. Valentin et al.
EUROPEAN JOURNAL OF CANCER (2016)
Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Elina Uusitalo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The use of electrodessication in the treatment of cutaneous neurofibromatosis: A retrospective patient satisfaction outcome assessment
C. G. Lutterodt et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2016)
Comparison of CAROC and FRAX in Fragility Fracture Patients: Agreement, Clinical Utility, and Implications for Clinical Practice
Nooshin Khobzi Rotondi et al.
JOURNAL OF RHEUMATOLOGY (2016)
Comparison of Clinical Risk Tools for Predicting Osteoporosis in Women Ages 50-64
Jennifer L. Pecina et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2016)
Counselling framework for moderate-penetrance cancer-susceptibility mutations
Nadine Tung et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Prevalence and clinical presentation of headache in a National Neurofibromatosis 1 Service and impact on quality of life
Shazia K. Afridi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas
Andre Vallejo Da Silva et al.
BMC CANCER (2015)
Age-specific risk of breast cancer in women with neurofibromatosis type 1
O. O. Seminog et al.
BRITISH JOURNAL OF CANCER (2015)
Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life
J. S. Cohen et al.
CLINICAL GENETICS (2015)
Treatment of Neurofibromas with a Carbon Dioxide Laser: A Retrospective Cross-Sectional Study of 106 Patients
Cecile Meni et al.
DERMATOLOGY (2015)
Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
Elina Uusitalo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Douglas F. Easton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Risk Assessment Tools for Osteoporosis Screening in Postmenopausal Women: A Systematic Review
Carolyn J. Crandall
CURRENT OSTEOPOROSIS REPORTS (2015)
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas
Valentina Pinna et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis
Chinwe C. Madubata et al.
GENETICS IN MEDICINE (2015)
Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems
Victor-Felix Mautner et al.
JOURNAL OF ATTENTION DISORDERS (2015)
Follow-Up of Six Patients with Neurofibromatosis 1-Related Osteoporosis Treated with Alendronate for 23 Months
Eetu Heerva et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands
R. van Minkelen et al.
CLINICAL GENETICS (2014)
Neuropsychological impairments in elderly Neurofibromatosis type 1 patients
Danielle de Souza Costa et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2014)
Neuropathic pruritus
Laurent Misery et al.
NATURE REVIEWS NEUROLOGY (2014)
Neurofibromatosis type I with breast cancer: not only for women!
Kuntegowdanahalli Chinnagiriyappa Lakshmaiah et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2014)
Sleep Disturbance as Part of the Neurofibromatosis Type 1 Phenotype in Adults
Guy D. Leschziner et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge
Emily C. Oates et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Healthcare transition in patients with rare genetic disorders with and without developmental disability: Neurofibromatosis 1 and williams-beuren syndrome
Andrea Van Lierde et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Neurofibromatosis type 1 and pregnancy complications: a population-based study
Anna R. Terry et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer
Berta Campos et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Neurofibromatosis 1-Related Osteopenia Often Progresses to Osteoporosis in 12 Years
Eetu Heerva et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Optimizing biologically targeted clinical trials for neurofibromatosis
David H. Gutmann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis
Emma M. M. Burkitt Wright et al.
JOURNAL OF MEDICAL GENETICS (2013)
Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis Type 1 Clinical article
Gavin P. Dunn et al.
JOURNAL OF NEUROSURGERY (2013)
Survival meta-analyses for > 1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
Matthias Kolberg et al.
NEURO-ONCOLOGY (2013)
18-Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) Evaluation of Nodular Lesions in Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas (PN) or Malignant Peripheral Nerve Sheath Tumors (MPNST)
Holly Meany et al.
PEDIATRIC BLOOD & CANCER (2013)
Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group
M. -J. Descheemaeker et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2013)
Breast cancer and other neoplasms in women with neurofibromatosis type 1: A retrospective review of cases in the Detroit metropolitan area
X. Wang et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Increased risk of breast cancer in women with NF1
Sara Aileen Madanikia et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro
Eetu Heerva et al.
BONE (2012)
Successful Treatment of Multiple Cutaneous Neurofibromas Using a Combination of Shave Excision and Laser Photothermocoagulation with a 1,444-nm Neodymium-Doped Yttrium Aluminum Garnet Laser
Hee Joo Kim et al.
DERMATOLOGIC SURGERY (2012)
A Controlled Register-Based Study of 460 Neurofibromatosis 1 Patients: Increased Fracture Risk in Children and Adults Over 41 Years of Age
Eetu Heerva et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Neoplasms Associated with Germline and Somatic NF1 Gene Mutations
Sachin Patil et al.
ONCOLOGIST (2012)
Vaporization of Cutaneous Neurofibromas with an Erbium: Yttrium-Aluminum-Garnet Laser: A Comparative Histologic Evaluation
Lukas K. Kriechbaumer et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2012)
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study
J. R. Kroep et al.
ANNALS OF ONCOLOGY (2011)
Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects
Laura Zinnamosca et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2011)
Evolving Pattern with Age of Cutaneous Signs in Neurofibromatosis Type 1: A Cross-Sectional Study of 728 Patients
T. A. Duong et al.
DERMATOLOGY (2011)
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989
D. Gareth R. Evans et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
6-18F-Fluoro-L-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to 123I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extraadrenal and Hereditary Pheochromocytomas and Paragangliomas: with Vesicular Monoamine Transporter Expression
C. Fottner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1
Douglas R. Stewart et al.
JOURNAL OF MEDICAL GENETICS (2010)
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
V-F Mautner et al.
JOURNAL OF MEDICAL GENETICS (2010)
High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1
S. Seitz et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Glomus Tumors in Neurofibromatosis Type 1: Genetic, Functional, and Clinical Evidence of a Novel Association
Hilde Brems et al.
CANCER RESEARCH (2009)
Health-Related Quality of Life in Patients with Neurofibromatosis Type 1
Yllka Kodra et al.
DERMATOLOGY (2009)
[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1
Victoria S. Warbey et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)
T. Tucker et al.
JOURNAL OF MEDICAL GENETICS (2009)
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs):: a long-term clinical study
R. E. Ferner et al.
ANNALS OF ONCOLOGY (2008)
How Does the Schwann Cell Lineage Form Tumors in NF1?
Steven L. Carroll et al.
GLIA (2008)
Relative fertility and mutation rate in neurofibromatosis
BIRGITTA SAMUELSSON et al.
HEREDITAS (2008)
Cerebrovascular dysplasia in neurofibromatosis type 1
A. G. Cairns et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Electrosurgical excision technique for the treatment of multiple cutaneous lesions in neurofibromatosis type I
Steven M. Levine et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2008)
Generalized metabolic bone disease in neurofibromatosis type I
Nicola Brunetti-Pierri et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
Victor-F. Mautner et al.
NEURO-ONCOLOGY (2008)
Health supervision for children with neurofibromatosis
Gerald B. Schaefer et al.
PEDIATRICS (2008)
Non-excision treatment of multiple cutaneous neurofibromas by laser photocoagulation
Tarek F. Elwakil et al.
LASERS IN MEDICAL SCIENCE (2008)
Vascular abnormalities in patients with neurofibromatosis syndrome type 1: Clinical spectrum, management, and results
Gustavo S. Oderich et al.
JOURNAL OF VASCULAR SURGERY (2007)
Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy?
Douglas R. Stewart et al.
CHEST (2007)
Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening
S. Sharif et al.
JOURNAL OF MEDICAL GENETICS (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Prenatal diagnosis of neurofibromatosis type 1: sonographic and MRI findings
Rachael L. McEwing et al.
PRENATAL DIAGNOSIS (2006)
Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1
M. Lammert et al.
JOURNAL OF MEDICAL GENETICS (2006)
Impact of neurofibromatosis 1 on quality of life: A cross-sectional study of 176 American cases
Patricia Z. Page et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
A prospective study of neurofibromatosis type 1 cancer incidence in the UK
L. Walker et al.
BRITISH JOURNAL OF CANCER (2006)
Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma
Birke Bausch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Neuropsychological function in adults with von Recklinghausen's neurofibromatosis
Marykay Pavol et al.
DEVELOPMENTAL NEUROPSYCHOLOGY (2006)
Decreased bone mineral density in patients with neurofibromatosis 1
M Lammert et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Decreased bone mineral density and content in neurofibromatosis type 1:: Lowest local values are located in the load-carrying parts of the body
T Kuorilehto et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Spinal deformity in neurofibromatosis type-1: diagnosis and treatment
AI Tsirikos et al.
EUROPEAN SPINE JOURNAL (2005)
Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma
L Amar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Do hormonal contraceptives stimulate growth of neurofibromas? A survey on 59 NFI patients
M Lammert et al.
BMC CANCER (2005)
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)
RE Ferner et al.
JOURNAL OF MEDICAL GENETICS (2004)
Elevated risk for MPNST in NF1 microdeletion patients
T De Raedt et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1)
DH Gutmann et al.
NEUROLOGY (2002)
BRCA1-related malignancies in a family presenting with von Recklinghausen's disease
M Ceccaroni et al.
GYNECOLOGIC ONCOLOGY (2002)
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 cardiovascular task force
JM Friedman et al.
GENETICS IN MEDICINE (2002)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Biochemical diagnosis of pheochromocytoma - Which test is best?
JWM Lenders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Quality-of-life impairment in neurofibromatosis type 1 -: A cross-sectional study of 128 cases
P Wolkenstein et al.
ARCHIVES OF DERMATOLOGY (2001)
Carbon dioxide laser for removal of multiple cutaneous neurofibromas
JC Moreno et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Insights into the pathogenesis of neurofibromatosis 1 vasculopathy
SJ Hamilton et al.
CLINICAL GENETICS (2000)
Modulation of spinal deformities in patients with neurofibromatosis Type 1
AA Durrani et al.
SPINE (2000)
Share Paper
